https://clinicaltrials.gov/ct2/show/NCT03336398?type=Intr&cond=Tinnitus&phase=012345&lupd_s=09%2F15%2F2020&lupd_d=14
Condition : Tinnitus
Interventions : Drug: Ketamine Hydrochloride in saline; Drug: Saline
Sponsor : New York State Psychiatric Institute
Recruiting
Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
NCT03336398
Wed, 08 Nov 2017 12:00:00 EST
Last Update Posted:
09/29/20 06:51AM
